These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 21376265)
1. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis. Liu L; Wang K; Zhu ZM; Shao JH Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265 [TBL] [Abstract][Full Text] [Related]
2. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis. Wu B; Guo D; Guo Y Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912 [TBL] [Abstract][Full Text] [Related]
3. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma. Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089 [TBL] [Abstract][Full Text] [Related]
4. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk. Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191 [TBL] [Abstract][Full Text] [Related]
5. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Hamajima N; Matsuo K; Suzuki T; Nakamura T; Matsuura A; Hatooka S; Shinoda M; Kodera Y; Yamamura Y; Hirai T; Kato T; Tajima K Cancer Lett; 2002 Jul; 181(1):81-5. PubMed ID: 12430182 [TBL] [Abstract][Full Text] [Related]
6. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk. Liu ZH; Bao ED Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052 [TBL] [Abstract][Full Text] [Related]
7. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk. Lv L; Wang P; Zhou X; Sun B Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481 [TBL] [Abstract][Full Text] [Related]
8. p53 Arg72Pro polymorphism confers the susceptibility to endometriosis among Asian and Caucasian populations. Lao X; Chen Z; Qin A Arch Gynecol Obstet; 2016 May; 293(5):1023-31. PubMed ID: 26493553 [TBL] [Abstract][Full Text] [Related]
9. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis. Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046 [TBL] [Abstract][Full Text] [Related]
10. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis. Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333 [TBL] [Abstract][Full Text] [Related]
11. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk. Cai K; Wang Y; Zhao X; Bao X Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013 [TBL] [Abstract][Full Text] [Related]
12. P53 Arg72Pro polymorphism and bladder cancer risk--meta-analysis evidence for a link in Asians but not Caucasians. Xu T; Xu ZC; Zou Q; Yu B; Huang XE Asian Pac J Cancer Prev; 2012; 13(5):2349-54. PubMed ID: 22901221 [TBL] [Abstract][Full Text] [Related]
13. The association between codon72 polymorphism of p53 gene and the risk of endometrial cancer: an updating meta-analysis. Lin X; Hou D; Huang C; Luo X Arch Gynecol Obstet; 2016 Aug; 294(2):353-9. PubMed ID: 26749437 [TBL] [Abstract][Full Text] [Related]
14. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis. Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250 [TBL] [Abstract][Full Text] [Related]
15. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Koushik A; Tranah GJ; Ma J; Stampfer MJ; Sesso HD; Fuchs CS; Giovannucci EL; Hunter DJ Int J Cancer; 2006 Oct; 119(8):1863-8. PubMed ID: 16721787 [TBL] [Abstract][Full Text] [Related]
16. Meta-analysis demonstrates association between Arg72Pro polymorphism in the P53 gene and susceptibility to keloids in the Chinese population. Wu Y; Wang B; Li YH; Xu XG; Luo YJ; Chen JZ; Wei HC; Gao XH; Chen HD Genet Mol Res; 2012 Jun; 11(2):1701-11. PubMed ID: 22843046 [TBL] [Abstract][Full Text] [Related]
17. Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis. Han PZ; Cao DH; Zhang XL; Ren ZJ; Wei Q Medicine (Baltimore); 2019 Jun; 98(25):e16135. PubMed ID: 31232967 [TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies. Yan Y; Wu R; Li S; He J Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169 [TBL] [Abstract][Full Text] [Related]
19. Updated meta-analysis of the TP53 Arg72Pro polymorphism and gastric cancer risk. Xiang B; Mi YY; Li TF; Liu PF Asian Pac J Cancer Prev; 2012; 13(5):1787-91. PubMed ID: 22901123 [TBL] [Abstract][Full Text] [Related]
20. TP53 Arg72Pro polymorphism (rs1042522) and risk of endometriosis among Asian and Caucasian populations. Li J; Chen Y; Mo Z; Li L Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():73-8. PubMed ID: 25889195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]